Koninklijke DSM NV (KDSKF.PK)

KDSKF.PK on OTC Markets Group - US Other OTC and Grey Market

52.30USD
28 Aug 2015
Change (% chg)

-- (--)
Prev Close
$52.30
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
216
52-wk High
$65.70
52-wk Low
$49.50

KDSKF.PK

Chart for KDSKF.PK

About

Koninklijke DSM N.V. (Royal DSM) is a global science-based company, engaged in health, nutrition and materials. The Company operates in segments: Nutrition, Performance Materials, Polymer Intermediates, Innovation Center and Corporate Activities. DSM Nutritional Products is the supplier of essential nutrients, such as vitamins,... (more)

Overall

Beta: 0.83
Market Cap(Mil.): €8,280.24
Shares Outstanding(Mil.): 181.43
Dividend: 0.55
Yield (%): 3.62

Financials

  KDSKF.PK Industry Sector
P/E (TTM): 94.92 27.00 32.34
EPS (TTM): 0.48 -- --
ROI: 0.99 6.14 13.43
ROE: 1.50 7.14 15.14
Search Stocks

BRIEF-Koninklijke DSM`s conclusion that canthaxanthin is GRAS for chicken breeders accepted by FDA

* DSM's conclusion that canthaxanthin is GRAS for chicken breeders is accepted by FDA, opening new doors for CAROPHYLL RED 10 pct Source text: http://bit.ly/1JkNzCZ Further company coverage: (Gdynia Newsroom)

27 Aug 2015

DSM Q2 earnings rise 6 percent, keeps guidance

AMSTERDAM, Aug 4 - DSM, the Dutch maker of nutritional supplements and high-performance materials, on Tuesday reported a 6 percent rise in second-quarter core earnings, driven by higher volume and positive exchange rate effects.

04 Aug 2015

CORRECTED-EU mergers and takeovers (July 23)

BRUSSELS, July 23 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

24 Jul 2015

EU clears CVC purchase of majority stake in DSM chemical units

July 23 - European antitrust regulators said on Thursday it approved CVC Capital Partners' acquisition of a majority stake in two chemicals subsidiaries of Dutch food and dietary supplements maker DSM.

23 Jul 2015

EU mergers and takeovers (July 22)

BRUSSELS, July 20 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

22 Jul 2015

BRIEF-DSM and Medday to produce pharmaceutical grade D-Biotin

* Medday and DSM announce a partnership to produce pharmaceutical grade D-Biotin to treat progressive multiple sclerosis

17 Jun 2015

BRIEF-Koninklijke DSM announces joint venture with Sobisco in India

* Announces joint venture with Sobisco to produce fortified foods and beverages for Eastern India

05 Jun 2015

UPDATE 2-Top EU companies urge drastic cuts in greenhouse gas emissions

* Want tough action from Paris U.N. summit in December (Updates with quotes from Kerry, Fabius, DSM)

21 May 2015

BRIEF-DSM finalizes sale of DSM Synres to Standard Investment

* DSM Synres realizes sales of about 50 mln euro with around 80 employees

02 Apr 2015

UPDATE 1-DSM sells 65 percent stake in chemicals to CVC for at least 300 mln euros

* Deal will refocus company on less cyclical nutrition businesses

16 Mar 2015

Earnings vs. Estimates

Search Stocks